Dobroslav Melamed
Founder at CANNABOTECH LTD
Net worth: - $ as of 30/03/2024
Profile
Dr. Dobroslav Melamed is an Independent Non-Executive Director at XTL Biopharmaceuticals Ltd., a Director & Chief Technology Officer at Trioxebo Ltd., a Director & Chief Technology Officer at Trioxmed Ltd., a Director & Chief Technology Officer at Trioxnano Ltd.
and a President & Director at Insight Biopharmaceuticals Ltd.
He is on the Board of Directors at Cannabotech Ltd., XTL Biopharmaceuticals Ltd., Venture Rif Capital Ltd., Trioxebo Ltd., Trioxmed Ltd., Trioxnano Ltd.
and Insight Biopharmaceuticals Ltd.
Dr. Melamed was previously employed as a Co-Founder by Peri-Ness Technologies Ltd.
and a President by SciVac Ltd.
He received his undergraduate degree from Bar-Ilan University, a graduate degree from Bar-Ilan University and a doctorate degree from Bar-Ilan University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 21/03/2023 | 0 ( -.--% ) | - $ | 30/03/2024 |
Dobroslav Melamed active positions
| Companies | Position | Start |
|---|---|---|
| XTL BIOPHARMACEUTICALS LTD. | Director/Board Member | 07/12/2014 |
| CANNABOTECH LTD | Founder | 01/01/2019 |
| Venture Rif Capital Ltd. | Director/Board Member | - |
| Trioxmed Ltd. | Chief Tech/Sci/R&D Officer | - |
| Trioxebo Ltd. | Chief Tech/Sci/R&D Officer | - |
Insight Biopharmaceuticals Ltd.
 Insight Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Insight Biopharmaceuticals Ltd. is an Israeli company that manufactures and commercializes biosimilars and new antibody therapeutics. The private company is based in Rehovot, Israel. | President | - |
| Trioxnano Ltd. | Chief Tech/Sci/R&D Officer | - |
Former positions of Dobroslav Melamed
| Companies | Position | End |
|---|---|---|
SciVac Ltd.
 SciVac Ltd. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., SciVac Ltd. is an Israeli company that develops and markets biological products for human healthcare. The private company is based in Rehovot, Israel. SciVac was acquired by Levon Resources Ltd. on July 09, 2015 for $73.16 million. | President | 31/08/2014 |
Peri-Ness Technologies Ltd.
 Peri-Ness Technologies Ltd. Pharmaceuticals: MajorHealth Technology Peri-Ness Technologies Ltd. operates as a biotechnology company focusing on addressing the problems of male fertility. The firm’s product is a systemic protein-based drug for treatment of male sub-fertility. The company was founded by Benjamin Bartoov, Attar Michal Ben, Dobroslav Melamed and Moshe Mizrahy in 2006 and is headquartered in Givat Shmuel, Israel. | Founder | - |
Training of Dobroslav Melamed
| Bar-Ilan University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| XTL BIOPHARMACEUTICALS LTD. | Health Technology |
| CANNABOTECH LTD | Health Technology |
| Private companies | 7 |
|---|---|
Peri-Ness Technologies Ltd.
Peri-Ness Technologies Ltd. Pharmaceuticals: MajorHealth Technology Peri-Ness Technologies Ltd. operates as a biotechnology company focusing on addressing the problems of male fertility. The firm’s product is a systemic protein-based drug for treatment of male sub-fertility. The company was founded by Benjamin Bartoov, Attar Michal Ben, Dobroslav Melamed and Moshe Mizrahy in 2006 and is headquartered in Givat Shmuel, Israel. | Health Technology |
Insight Biopharmaceuticals Ltd.
Insight Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Insight Biopharmaceuticals Ltd. is an Israeli company that manufactures and commercializes biosimilars and new antibody therapeutics. The private company is based in Rehovot, Israel. | Health Technology |
SciVac Ltd.
SciVac Ltd. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., SciVac Ltd. is an Israeli company that develops and markets biological products for human healthcare. The private company is based in Rehovot, Israel. SciVac was acquired by Levon Resources Ltd. on July 09, 2015 for $73.16 million. | Health Technology |
| Venture Rif Capital Ltd. | |
| Trioxmed Ltd. | |
| Trioxebo Ltd. | |
| Trioxnano Ltd. |
- Stock Market
- Insiders
- Dobroslav Melamed
